These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 13394196

  • 21. Livedoid vasculopathy - current aspects of diagnosis and treatment of cutaneous infarction.
    Kerk N, Goerge T.
    J Dtsch Dermatol Ges; 2013 May; 11(5):407-10. PubMed ID: 23437985
    [Abstract] [Full Text] [Related]

  • 22. Buerger's disease manifesting nodular erythema with livedo reticularis.
    Takanashi T, Horigome R, Okuda Y, Nose M, Matsuda M, Ikeda S.
    Intern Med; 2007 May; 46(21):1815-9. PubMed ID: 17978541
    [Abstract] [Full Text] [Related]

  • 23. Telangiectasias of the breasts showing diffuse dermal angiomatosis in a patient with diffuse livedo reticularis.
    Lemery R, Saillard C, Le Gall F, Bismut M, Dupuy A.
    Dermatol Online J; 2022 Oct 15; 28(5):. PubMed ID: 36809137
    [Abstract] [Full Text] [Related]

  • 24. LIVEDO RETICULARIS. A REVIEW.
    CHAMPION RH.
    Br J Dermatol; 1965 Apr 15; 77():167-79. PubMed ID: 14278789
    [No Abstract] [Full Text] [Related]

  • 25. Livedoid vasculopathy - a thrombotic disease.
    Kerk N, Goerge T.
    Vasa; 2013 Sep 15; 42(5):317-22. PubMed ID: 23989066
    [Abstract] [Full Text] [Related]

  • 26. [Physiological biocatalysts in therapy of blood vessel walls in venous and arterial circulatory disorders].
    SUCKOW KL.
    Med Klin; 1957 Sep 20; 52(38):1666-8. PubMed ID: 13482990
    [No Abstract] [Full Text] [Related]

  • 27. Livedo reticularis.
    Picascia DD, Pellegrini JR.
    Cutis; 1987 May 20; 39(5):429-32. PubMed ID: 3581915
    [Abstract] [Full Text] [Related]

  • 28. Livedoid vasculopathy secondary to high levels of lipoprotein(a).
    Vasconcelos R, Criado PR, Belda W.
    Br J Dermatol; 2011 May 20; 164(5):1111-3. PubMed ID: 21219292
    [No Abstract] [Full Text] [Related]

  • 29. [Livedo reticularis idiopathica et symptomatica; contribution to arteriolar pathology].
    HERZBERG JJ.
    Dermatol Wochenschr; 1956 Sep 29; 134(39):1045-53. PubMed ID: 13375166
    [No Abstract] [Full Text] [Related]

  • 30. [Acute arterial obliteration of the inferior extremities; treatment with intra-arterial injections, cicatrization of the sphacelous cutaneous zones].
    MARMASSE J.
    Arch Mal Coeur Vaiss; 1955 Jul 29; 48(7):706-7. PubMed ID: 13276052
    [No Abstract] [Full Text] [Related]

  • 31. [Necrosing livedo reticularis].
    Arruda S.
    Angiologia; 1971 Jul 29; 23(3):93-102. PubMed ID: 5563702
    [No Abstract] [Full Text] [Related]

  • 32. Response of livedoid vasculopathy to rivaroxaban.
    Winchester DS, Drage LA, Davis MD.
    Br J Dermatol; 2015 Apr 29; 172(4):1148-50. PubMed ID: 25255997
    [No Abstract] [Full Text] [Related]

  • 33. The management of livedoid vasculopathy focused on direct oral anticoagulants (DOACs): four case reports successfully treated with rivaroxaban.
    Franco Marques G, Criado PR, Alves Batista Morita TC, Cajas García MS.
    Int J Dermatol; 2018 Jun 29; 57(6):732-741. PubMed ID: 29663354
    [Abstract] [Full Text] [Related]

  • 34. Primary oxalosis with livedo reticularis.
    Greer KE, Cooper PH, Campbell F, Westervelt FB.
    Arch Dermatol; 1980 Feb 29; 116(2):213-4. PubMed ID: 7356356
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Amantadine-Induced Livedo Racemosa.
    Criado PR, Alavi A, Valente NY, Sotto MN.
    Int J Low Extrem Wounds; 2016 Mar 29; 15(1):78-81. PubMed ID: 26338517
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Peripheral vascular diseases and anticoagulant therapy].
    HASHIMOTO Y.
    Naika; 1962 Feb 01; 9():251-9. PubMed ID: 13905218
    [No Abstract] [Full Text] [Related]

  • 39. Oxalosis and livedo reticularis.
    Jorquera-Barquero E, Súarez-Marrero MC, Fernández Girón F, Borrero Martín JJ.
    Actas Dermosifiliogr; 2013 Nov 01; 104(9):815-8. PubMed ID: 23103120
    [Abstract] [Full Text] [Related]

  • 40. [Results of local use of a heparinoid substance in the treatment of peripheral vascular diseases].
    CECCHETTI G, GAIDO A.
    Gazz Med Ital; 1957 Aug 01; 116(8):333-8. PubMed ID: 13462098
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.